NEXT GENERATION DNA VACCINES FOR HIV-1

REFERENCES

• Barouch D.H., Letvin N.L. DNA Vaccination for hiv-1 and siv. Intervirology 2000; 43(4–6)282–287
   PubMedGoogle Scholar
• Kjerrstrom A., Hinkula J., Engstrom G., Ovod V., Krohn K., Benthin R., Wahren B. Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines. Virology 2001; 284(1)46–61
   PubMedGoogle Scholar
• Shen X., Siliciano R.F. Preventing AIDS but not HIV-1 Infection with a DNA Vaccine. Science 2000; 290(5491)463–465
   PubMedGoogle Scholar
• Huang Y., Kong W.P., Nabel G.J. Human Immunodeficiency Virus Type 1-specific Immunity after Genetic Immunization is Enhanced by Modification of Gag and Pol Expression. J. Virol. 2001; 75(10)4947–4951
   PubMedGoogle Scholar
• Kim J.J., Weiner D.B. Development of Multicomponent DNA Vaccination Strategies Against HIV. Curr. Opin. Mol. Ther. 1999; 1(1)43–49
   PubMedGoogle Scholar
• Ayyavoo V., Kudchodkar S., Ramanathan M.P., Le P., Muthumani K., Megalai N.M., Dentchev T., Santiago-Barrios L., Mrinalini C., Weiner D.B. Immunogenicity of a Novel DNA Vaccine Cassette Expressing Multiple Human Immunodeficiency Virus (HIV-1) Accessory Genes. AIDS 2000, Jan 7; 14(1)1–9
   PubMedGoogle Scholar
• Barouch D.H., Craiu A., Kuroda M.J., Schmitz J.E., Zheng X.X., Santra S., Frost J.D., Krivulka G.R., Lifton M.A., Crabbs C.L., Heidecker G., Perry H.C., Davies M.E., Xie H., Nickerson C.E., Steenbeke T.D., Lord C.I., Montefiori D.C., Strom T.B., Shiver J.W., Lewis M.G., Letvin N.L. Augmentation of Immune Responses to HIV-1 and Simian Immunodeficiency Virus DNA Vaccines by IL-2/Ig Plasmid Administration in Rhesus Monkeys. Proc. Natl. Acad. Sci. USA 2000; 97(8)4192–4197
   PubMedGoogle Scholar
• Akahata W., Ido E., Shimada T., Katsuyama K., Yamamoto H., Uesaka H., Ui M., Kuwata T., Takahashi H., Hayami M. DNA Vaccination of Macaques by a Full Genome HIV-1 Plasmid which Produces Noninfectious Virus Particles. Virology 2000; 275(1)116–124
   PubMedGoogle Scholar
• Boyer J.D., Cohen A.D., Ugen K.E., Edgeworth R.L., Bennett M., Shah A., Schumann K., Nath B., Javadian A., Bagarazzi M.L., Kim J., Weiner D.B. Therapeutic Immunization of HIV-Infected Chimpanzees Using HIV-1 Plasmid Antigens and Interleukin-12 Expressing Plasmids. AIDS 2000; 14(11)1515–1522
   PubMedGoogle Scholar
• Lockey T.D., Slobod K.S., Caver T.E., D′Costa S., Owens R.J., McClure H.M., Compans R.W., Hurwitz J.L. Multi-Envelope HIV Vaccine Safety and Immunogenicity in Small Animals and Chimpanzees. Immunol. Res. 2000; 2(1)7–21
   Google Scholar
• Barouch D.H., Craiu A., Santra S., Egan M.A., Schmitz J.E., Kuroda M.J., Fu T.M., Nam J.H., Wyatt L.S., Lifton M.A., Krivulka G.R., Nickerson C.E, Lord C.I., Moss B., Lewis M.G., Hirsch V.M., Shiver J.W., Letvin N.L. Elicitation of High-Frequency Cytotoxic T-lymphocyte Responses Against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys. J. Virol. 2001; 75(5)2462–2467
   PubMedGoogle Scholar
• Otten G.R., Doe B., Schaefer M., Chen M., Selby M.J., Goldbeck C., Hong M., Xu F., Ulmer J.B. Relative Potency of Cellular and Humoral Immune Responses Induced by DNA Vaccination. Intervirology 2000; 43(4–6) 227–232
   PubMedGoogle Scholar
• Zur Megede J., Chen M.C., Doe B., Schaefer M., Greer C.E., Selby M., Otten G.R., Barnett S.W. Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Gag Gene. J. Virol. 2000; 74(6)2628–2635
   PubMedGoogle Scholar
• Qiu J.T., Song R., Dettenhofer M., Tian C., August T., Felber B.K., Pavlakis G.N., Yu X.F. Evaluation of Novel Human Immunodeficiency Virus Type 1 Gag DNA Vaccines for Protein Expression in Mammalian Cells and Induction of Immune Responses. J. Virol. 1999; 73(11)9145–9152
   PubMedGoogle Scholar
• Sin J., Kim J.J., Pachuk C., Satishchandran C., Weiner D.B. DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-specific Th1-type CD4(+) T-cell-Mediated Protective Immunity Against Herpes Simplex Virus type 2 In Vivo. J. Virol. 2000; 74(23)11173–11180
   PubMedGoogle Scholar
• Sin J.I., Kim J.J., Arnold R.L., Shroff K.E., McCallus D., Pachuk C., McElhiney S.P., Wolf M.W., Pompa-de Bruin S.J., Higgins T.J., Ciccarelli R.B., Weiner D.B. IL-12 gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-type CD4+ T Cell-mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge. J. Immunol. 1999; 162(5)2912–2921
   PubMedGoogle Scholar
• Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo Engineering of a Cellular Immune Response by Coadministration of IL-12 Expression Vector with a DNA Immunogen. J. Immunol. 1997; 158(2)816–826
   PubMedGoogle Scholar
• Sin J.I., Kim J.J., Ugen K.E., Ciccarelli R.B., Higgins T.J., Weiner D.B. Enhancement of Protective Humoral (Th2) and Cell-Mediated (Th1) Immune Responses Against Herpes Simplex Virus-2 Through Co-Delivery of Granulocyte-Macrophage Colony-Stimulating Factor Expression Cassettes. Eur. J. Immunol. 1998; 28(11)3530–3540
   PubMedGoogle Scholar
• Nappi F., Schneider R., Zolotukhin A., Smulevitch S., Michalowski D., Bear J., Felber B.K., Pavlakis G.N. Identification of a Novel Posttranscriptional Regulatory Element by Using a Rev- and RRE-Mutated Human Immunodeficiency Virus Type 1 DNA Proviral Clone as a Molecular Trap. J. Virol. 2001; 75(10)4558–4569
   PubMed Web of Science ®Google Scholar